Literature DB >> 12515865

Evidence that exposure of the telomere 3' overhang sequence induces senescence.

Guang-Zhi Li1, Mark S Eller, Reza Firoozabadi, Barbara A Gilchrest.   

Abstract

Normal human cells cease proliferation after a finite number of population doublings, a phenomenon termed replicative senescence. This process, first convincingly described by Hayflick and Moorhead [Hayflick, L. & Moorhead, P. S. (1961) Exp. Cell Res. 25, 595-621] for cultured human fibroblasts 40 years ago, is suggested to be a fundamental defense against cancer. Several events have been demonstrated to induce the senescent phenotype including telomere shortening, DNA damage, oxidative stress, and oncogenic stimulation. The molecular mechanisms underlying senescence are poorly understood. Here we report that a 1-week exposure to oligonucleotide homologous to the telomere 3'-overhang sequence TTAGGG (T-oligo) similarly specifically induces a senescent phenotype in cultured human fibroblasts, mimicking serial passage or ectopic expression of a dominant negative form of the telomeric repeat binding factor, TRF2(DN). We propose that exposure of the 3' overhang due to telomere loop disruption may occur with critical telomere shortening or extensive acute DNA damage and that the exposed TTAGGG tandem repeat sequence then triggers DNA-damage responses. We further demonstrate that these responses can be induced by treatment with oligonucleotides homologous to the overhang in the absence of telomere disruption, a phenomenon of potential therapeutic importance.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12515865      PMCID: PMC141029          DOI: 10.1073/pnas.0235444100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

1.  Telomere shortening triggers a p53-dependent cell cycle arrest via accumulation of G-rich single stranded DNA fragments.

Authors:  G Saretzki; N Sitte; U Merkel; R E Wurm; T von Zglinicki
Journal:  Oncogene       Date:  1999-09-16       Impact factor: 9.867

2.  Telomere end-replication problem and cell aging.

Authors:  M Z Levy; R C Allsopp; A B Futcher; C W Greider; C B Harley
Journal:  J Mol Biol       Date:  1992-06-20       Impact factor: 5.469

3.  Failure to phosphorylate the retinoblastoma gene product in senescent human fibroblasts.

Authors:  G H Stein; M Beeson; L Gordon
Journal:  Science       Date:  1990-08-10       Impact factor: 47.728

4.  A biomarker that identifies senescent human cells in culture and in aging skin in vivo.

Authors:  G P Dimri; X Lee; G Basile; M Acosta; G Scott; C Roskelley; E E Medrano; M Linskens; I Rubelj; O Pereira-Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-26       Impact factor: 11.205

Review 5.  DNA repair fine structure and its relations to genomic instability.

Authors:  V A Bohr
Journal:  Carcinogenesis       Date:  1995-12       Impact factor: 4.944

6.  DNA damage enhances melanogenesis.

Authors:  M S Eller; K Ostrom; B A Gilchrest
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-06       Impact factor: 11.205

Review 7.  Replicative senescence: an old lives' tale?

Authors:  J Campisi
Journal:  Cell       Date:  1996-02-23       Impact factor: 41.582

8.  Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen.

Authors:  A Noda; Y Ning; S F Venable; O M Pereira-Smith; J R Smith
Journal:  Exp Cell Res       Date:  1994-03       Impact factor: 3.905

9.  p21Waf1/Cip1/Sdi1 induces permanent growth arrest with markers of replicative senescence in human tumor cells lacking functional p53.

Authors:  L Fang; M Igarashi; J Leung; M M Sugrue; S W Lee; S A Aaronson
Journal:  Oncogene       Date:  1999-05-06       Impact factor: 9.867

10.  Mammalian telomeres end in a large duplex loop.

Authors:  J D Griffith; L Comeau; S Rosenfield; R M Stansel; A Bianchi; H Moss; T de Lange
Journal:  Cell       Date:  1999-05-14       Impact factor: 41.582

View more
  39 in total

1.  Topical DNA oligonucleotide therapy reduces UV-induced mutations and photocarcinogenesis in hairless mice.

Authors:  David A Goukassian; Elizabeth Helms; Harry van Steeg; Conny van Oostrom; Jag Bhawan; Barbara A Gilchrest
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-03       Impact factor: 11.205

2.  A role for WRN in telomere-based DNA damage responses.

Authors:  Mark S Eller; Xiaodong Liao; SuiYang Liu; Kendra Hanna; Helena Bäckvall; Patricia L Opresko; Vilhelm A Bohr; Barbara A Gilchrest
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-02       Impact factor: 11.205

3.  T-oligos inhibit growth and induce apoptosis in human ovarian cancer cells.

Authors:  Sibaji Sarkar; Douglas V Faller
Journal:  Oligonucleotides       Date:  2011-01-31

4.  Recovery of cell cycle delay following targeted gene repair by oligonucleotides.

Authors:  Luciana Ferrara; Julia U Engstrom; Timothy Schwartz; Hetal Parekh-Olmedo; Eric B Kmiec
Journal:  DNA Repair (Amst)       Date:  2007-06-11

Review 5.  Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer.

Authors:  Paula J Bates; Damian A Laber; Donald M Miller; Shelia D Thomas; John O Trent
Journal:  Exp Mol Pathol       Date:  2009-01-20       Impact factor: 3.362

6.  Non-small cell lung cancer is susceptible to induction of DNA damage responses and inhibition of angiogenesis by telomere overhang oligonucleotides.

Authors:  Neelu Puri; Ryan T Pitman; Richard E Mulnix; Terrianne Erickson; Audra N Iness; Connie Vitali; Yutong Zhao; Ravi Salgia
Journal:  Cancer Lett       Date:  2013-09-14       Impact factor: 8.679

7.  Nontelomeric TRF2-REST interaction modulates neuronal gene silencing and fate of tumor and stem cells.

Authors:  Peisu Zhang; Michael J Pazin; Catherine M Schwartz; Kevin G Becker; Robert P Wersto; Caroline M Dilley; Mark P Mattson
Journal:  Curr Biol       Date:  2008-09-25       Impact factor: 10.834

8.  Molecular distinctions between stasis and telomere attrition senescence barriers shown by long-term culture of normal human mammary epithelial cells.

Authors:  James C Garbe; Sanchita Bhattacharya; Batul Merchant; Ekaterina Bassett; Karen Swisshelm; Heidi S Feiler; Andrew J Wyrobek; Martha R Stampfer
Journal:  Cancer Res       Date:  2009-09-22       Impact factor: 12.701

9.  Telomeric DNA induces p53-dependent reactive oxygen species and protects against oxidative damage.

Authors:  Margaret S Lee; Mina Yaar; Mark S Eller; Thomas M Rünger; Ying Gao; Barbara A Gilchrest
Journal:  J Dermatol Sci       Date:  2009-11-10       Impact factor: 4.563

10.  Star-shaped tetraspermine enhances cellular uptake and cytotoxicity of T-oligo in prostate cancer cells.

Authors:  Vidula Kolhatkar; Hiren Khambati; Asawari Lote; Peter Shanine; Thomas Insley; Soumyo Sen; Gnanasekar Munirathinam; Petr Král; Rohit Kolhatkar
Journal:  Pharm Res       Date:  2014-08-05       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.